Drug Shortage Report for MYLAN-CYCLOBENZAPRINE

Last updated on 2018-06-08 History
Report ID 2465
Drug Identification Number 02231353
Brand name MYLAN-CYCLOBENZAPRINE
Common or Proper name Cyclobenzaprine
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) CYCLOBENZAPRINE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code M03BX
ATC description MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-02-20
Estimated end date Unknown
Actual end date 2018-06-07
Shortage status Resolved
Updated date 2018-06-08
Company comments discontinued in ID 51945. Last lot 3044006 exp 31-may-2019
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2018-06-08 French Compare
v12 2018-06-08 English Compare
v11 2018-02-21 French Compare
v10 2018-02-21 English Compare
v9 2018-02-15 French Compare
v8 2018-02-15 English Compare
v7 2017-05-03 French Compare
v6 2017-05-03 English Compare
v5 2017-04-21 English Compare
v4 2017-03-14 French Compare
v3 2017-03-14 English Compare
v2 2017-03-14 French Compare
v1 2017-03-14 English Compare

Showing 1 to 13 of 13